Minimally invasive surgery may offer safer option for early endometrial cancer

NCT ID NCT07514078

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two surgical approaches for early-stage endometrial cancer: laparoscopic staging (minimally invasive) and open staging laparotomy (traditional open surgery). Researchers will enroll 30 patients to see if laparoscopy is as safe and effective as open surgery, with fewer complications and faster recovery. The goal is to determine if laparoscopy can be a standard alternative for treating early-stage endometrial cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

laparoscopic staging (a minimally invasive surgical procedure)

What this could lead to

If successful, this could show that laparoscopic staging is a safer and equally effective alternative to open surgery for early-stage endometrial cancer, leading to faster recovery and fewer complications.

What could go wrong

This is a small, early-phase study with only 30 participants, so results may not apply to all patients. There is also a risk of surgical complications like injury to organs or bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial cancer endometrial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••